Depressive DisordersSuicidalityKetamine

Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine

This theory-building paper (2020) proposes that the circadian rhythm may be an important factor in the antidepressant effect of ketamine therapies.

Authors

  • Kohtala, S.
  • Alitalo, O.
  • Rosenholm, M.

Published

Pharmacology and Therapeutics
meta Study

Abstract

Several studies have demonstrated the effectiveness of ketamine in rapidly alleviating depression and suicidal ideation. Intense research efforts have been undertaken to expose the precise mechanism underlying the antidepressant action of ketamine; however, the translation of findings into new clinical treatments has been slow. This translational gap is partially explained by a lack of understanding of the function of time and circadian timing in the complex neurobiology around ketamine. Indeed, the acute pharmacological effects of a single ketamine treatment last for only a few hours, whereas the antidepressant effects peak at around 24 hours and are sustained for the following few days. Numerous studies have investigated the acute and long-lasting neurobiological changes induced by ketamine; however, the most dramatic and fundamental change that the brain undergoes each day is rarely taken into consideration. Here, we explore the link between sleep and circadian regulation and rapid-acting antidepressant effects and summarize how diverse phenomena associated with ketamine’s antidepressant actions - such as cortical excitation, synaptogenesis, and involved molecular determinants - are intimately connected with the neurobiology of wake, sleep, and circadian rhythms. We review several recently proposed hypotheses about rapid antidepressant actions, which focus on sleep or circadian regulation, and discuss their implications for ongoing research. Considering these aspects may be the last piece of the puzzle necessary to gain a more comprehensive understanding of the effects of rapid-acting antidepressants on the brain.

Available with Blossom Pro

Research Summary of 'Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine'

Introduction

Kohtala and colleagues frame their review around an important translational gap in ketamine research: although ketamine produces rapid antidepressant effects within hours and sustained benefits that peak about 24 hours after a single dose, mechanistic insights from molecular and animal studies have not translated efficiently into improved, reliably sustained clinical treatments. Earlier research has identified multiple molecular and synaptic mechanisms implicated in ketamine's action—NMDAR blockade, glutamate bursts, AMPAR activation, BDNF-TrkB signalling, mTOR/ERK pathways and synaptogenesis—but these pharmacological explanations do not account for the mismatch between ketamine's short-lived acute pharmacology and its delayed, longer-lasting clinical benefits. This review sets out to examine how sleep and circadian biology intersect with the neurobiology of ketamine's rapid antidepressant effects. The authors propose that daily physiological processes—particularly sleep homeostasis and circadian timing—may be critical to understanding how transient pharmacological perturbations produce longer-term changes in mood and neural circuits. They therefore review basic sleep and circadian mechanisms, summarise evidence linking these systems to ketamine's molecular and systems-level effects, and discuss recently proposed hypotheses that explicitly couple sleep/circadian processes to rapid-acting antidepressant action.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    meta
  • Journal
  • Compound
  • Topics
  • APA Citation

    Kohtala, S., Alitalo, O., Rosenholm, M., Rozov, S., & Rantamäki, T. (2021). Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine. Pharmacology & Therapeutics, 221, 107741. https://doi.org/10.1016/j.pharmthera.2020.107741

References (13)

Papers cited by this study that are also in Blossom

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A. et al. · Neuropsychopharmacology (2016)

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

Abdallah, C. G., Averill, L. A., Gueorguieva, R. et al. · Neuropsychopharmacology (2020)

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Murrough, J. W., Iosifescu, D. V., Chang, L. C. et al. · American Journal of Psychiatry (2013)

Nitrous Oxide for Treatment-Resistant Major Depression: a Proof-of-Concept Trial

Nagele, P., Duma, A., Kopec, M. et al. · Biological Psychiatry (2015)

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

Newport, D. J., Carpenter, L. L., Mcdonald, W. M. et al. · American Journal of Psychiatry (2015)

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects

Nugent, A. C., Ballard, E. D., Gould, T. D. et al. · Molecular Psychiatry (2018)

223 cited
Show all 13 references
Mechanisms of ketamine action as an antidepressant

Zanos, P., Gould, T. D. · Molecular Psychiatry (2018)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P., Moaddel, P. J., Morris, P. J. et al. · Nature (2016)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.